New migraine drug from Pfizer

Discussion in 'Fibromyalgia Main Forum' started by Spedding, Dec 27, 2002.

  1. Spedding

    Spedding New Member

    For people with FM and the migraines that come with it...

    From The Globe and Mail, Toronto, Saturday, December 28, 2002, Page B7:

    Pfizer Inc. said yesterday the U.S. Food and Drug Administration approved its experimental treatment for migraine headaches, Relpax, after lengthy regulatory delays. New York-based Pfizer said the drug was shown in clinical trials to relieve migraine pain and associated symptoms, including nausea and sensitivity to light and sound. It will compete with other members of the "triptan" family of migraine drugs, including GlaxoSmithKline Inc.'s popular Imitrex injectable treatment.

    Spedding

  2. Mikie

    Mikie Moderator

    Thanks for this info. Migraine headaches are such a problem for so many with our illnesses.

    Love, Mikie